1. ASK, A.L., FAGERVALL, I. & ROSS, S.B. (1983). Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain. Naunyn Schmiedeberg’s Arch. Pharmacol., 324, 79–87.
2. ASK, A.L., FAGERVALL, I. & ROSS, S.B. (1984). Amifla- mine (FLA 336(+)), a reversible MAO-A inhibitor selective for serotonergic neurones. In Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors. Tipton, K.F., Dostert, P. & Strolin Benedetti, M. (eds) London: Academic Press (in press).
3. CAMPBELL, I.C., SHILING, D.J., LIPPER, S., SLATER, S. & MURPHY, D.L. (1979). Biochemical measure of monoamine oxidase type A and type B inhibitor. Effects in man. J. Psychiat. Res., 15, 77–84.
4. CLARK, B. (1967). The in vitro inhibition of the N- demethylation of pethidine by phenelzine (phenethylhydrazine). Biochem. Pharmac, 16, 2369–2385.
5. CLARK, B., THOMPSON, J.W. & WIDDRINGTON, G. (1972). Analysis of the inhibition of pethidine N- demethylation by monoamine oxidase inhibitors and some other drugs with special reference to drug interac tions in man. Br. J. Pharmac, 44, 89–99.